News on Medial

MiClient raises seed round from IAN Group, others

EntrackrEntrackr ยท 1y ago
MiClient raises seed round from IAN Group, others
Medial

MiClient, an AI-driven B2B sales enablement platform, has raised Rs 3.9 crore in its seed funding round led by IAN Group with participation from Anicut, GSF, RTAF, and Keiretsu. Vikas Kuthiala and Pratik Mathurkar from IAN led the round. The round follows an initial pre-seed investment in October 2023 from 100x.VC. The proceeds will be used to build a stronger team and expand market presence across more geographies in India. In addition to market expansion, MiClient is developing an AI-based model to create quotations and invoices in seconds, further streamlining the sales process for its users. Led by Swati Sharma, MiClientโ€™s easy-to-use CPQ platform helps sales teams close deals three times faster, with the average deal now closing in just 10 days. Expanding further into Indiaโ€™s industrial hubs, MiClient is executing a feet-on-the-street go-to-market strategy. MiClient is expanding into more industrial hubs across India using a direct sales approach. With over 150 customers and over 1,500 users, the company serves SMEs, particularly in the B2B manufacturing sector, with a user-friendly platform.

Related News

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr ยท 3m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IANโ€™s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditionsโ€”ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

Contrails AI raises $1 Mn in pre-seed round from Huddle Ventures and IAN Group

EntrackrEntrackr ยท 13d ago
Contrails AI raises $1 Mn in pre-seed round from Huddle Ventures and IAN Group
Medial

Contrails AI raises $1 million in pre-seed round from Huddle Ventures and IAN Group. Trust and safety-tech AI startup Contrails AI has raised $1 million in a pre-seed funding round co-led by Huddle Ventures and IAN Group. The fresh funds will be used to fuel the US and EU pilots running across industries such as marketplaces, media houses, financial firms, and leading digital platforms, Contrails said in a press release. Co-founded by Digvijay Singh and Amitabh Kumar, Contrails AI aims to safeguard internet companies in the age of GenAI. The company delivers solutions trusted by marketplaces, media houses, financial services, and global digital platforms. According to the Bengaluru-based startup, it combines deep-tech innovation with multimodal AI expertise to engineer a compliance-ready safety infrastructure that safeguards digital ecosystems globally. By partnering with the companies in services and technology, the startup aspires to drive adoption of trust & safety solutions while building an interconnected, secure digital ecosystem. Contrailsโ€™s proprietary forensics and manipulation detection AI delivers real-time analysis with layered explainability, enabling platform review teams to detect, assess, and act on threats proactively. The platform tackles the threat of cyber crimes with a multimodal approach across video, image, audio, and text, merging fraud detection with forensic DNA analysis and global data expertise. As per market research, from 500,000 in 2023 to 8 million in 2025, deepfake files have grown 16-fold and due to phishing attacks resulted in losses of $17,700 every minute.

Download the medial app to read full posts, comements and news.